CENI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 6.435
EU - Europa 4.151
AS - Asia 2.922
SA - Sud America 376
AF - Africa 97
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.033
Nazione #
US - Stati Uniti d'America 6.368
RU - Federazione Russa 1.538
PL - Polonia 826
SG - Singapore 824
CN - Cina 727
HK - Hong Kong 437
IT - Italia 356
IE - Irlanda 344
SE - Svezia 337
BR - Brasile 303
VN - Vietnam 273
KR - Corea 229
DE - Germania 195
FR - Francia 137
IN - India 109
FI - Finlandia 106
UA - Ucraina 98
GB - Regno Unito 95
JO - Giordania 76
JP - Giappone 76
AU - Australia 50
CH - Svizzera 45
CA - Canada 33
BD - Bangladesh 31
ID - Indonesia 29
AR - Argentina 27
CI - Costa d'Avorio 24
MO - Macao, regione amministrativa speciale della Cina 24
BE - Belgio 21
NG - Nigeria 19
ES - Italia 16
IQ - Iraq 16
MX - Messico 16
TR - Turchia 16
MA - Marocco 12
NL - Olanda 12
PK - Pakistan 12
ZA - Sudafrica 12
EC - Ecuador 11
VE - Venezuela 9
EG - Egitto 8
PH - Filippine 8
PY - Paraguay 7
UY - Uruguay 6
AL - Albania 5
CO - Colombia 5
TW - Taiwan 5
CL - Cile 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
SC - Seychelles 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
ET - Etiopia 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
NI - Nicaragua 2
PE - Perù 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
HR - Croazia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 14.033
Città #
Santa Clara 1.315
Warsaw 825
Ashburn 728
Singapore 594
Fairfield 478
Hong Kong 363
Dublin 344
Chandler 338
Woodbridge 261
Seoul 224
Cambridge 215
Seattle 206
Houston 188
San Jose 187
Beijing 180
Wilmington 175
Jacksonville 158
Ann Arbor 143
Hefei 115
Lawrence 112
The Dalles 111
Buffalo 110
Altamura 106
Ho Chi Minh City 85
Los Angeles 84
Princeton 81
Munich 79
Lauterbourg 76
Tokyo 74
Boardman 72
Dallas 72
Boston 69
Florence 67
Hanoi 63
Melbourne 50
New York 49
Paris 46
Mumbai 43
Shanghai 43
Bern 38
Council Bluffs 38
São Paulo 35
Moscow 34
Kent 33
San Diego 31
Medford 29
Orem 29
Pune 27
Helsinki 25
Abidjan 24
Falls Church 23
Brussels 21
Jakarta 21
Bremen 20
Clifton 19
Milan 19
Abuja 18
Turku 18
London 17
Dong Ket 16
Norwalk 16
Redondo Beach 16
Chicago 15
Da Nang 15
Phoenix 12
West Jordan 12
Yubileyny 12
Chennai 11
Guangzhou 11
Izmir 10
Rio de Janeiro 10
Frankfurt am Main 9
Hillsboro 9
Macao 9
Barcelona 8
Denver 8
Haiphong 8
Hanover 8
Poplar 8
Rome 8
Toronto 8
Andover 7
Biên Hòa 7
Casablanca 7
Fiesole 7
Montreal 7
Porto Alegre 7
Stockholm 7
Charlotte 6
Dhaka 6
El Monte 6
Johannesburg 6
New Delhi 6
Ottawa 6
Secaucus 6
Auburn Hills 5
Brooklyn 5
Cairo 5
Düsseldorf 5
Hải Dương 5
Totale 9.403
Nome #
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 358
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 351
Magnetic hyperthermia and oxidative damage to dna of human hepatocarcinoma cells 336
8-Oxo-7,8-dihydro-2'-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study. 320
Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective 292
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1 249
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 241
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells 227
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 224
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC) 222
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model. 215
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 210
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. 205
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. 204
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. 196
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro 192
Alcohol induced hepatic fibrosis: role of acetaldehyde. 186
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 185
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells 183
The AAA+ ATPase RuvBL1 localizes to mitochondria and supports HCC cell metabolism. 182
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms 180
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 180
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 179
Aldehyde Dehydrogenase-2 (aldh2) Gene Is Differently Expressed In Human Liver Fat-storing Cells (hfsc) and Liver-tissues 179
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells 172
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. 171
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 169
Intracellular signaling pathways activated by reactive oxygen species regulate proliferation and collagen synthesis of human hepatic stellate cells 168
Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development 168
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 166
Peroxisome proliferator-activated receptor gamma (PPARgamma) transcriptional activity is inhibited by acetaldehyde in human hepatic stellate cells (HSC) 165
Acetaldehyde inhibits peroxisome proliferator-activated receptor gamma (PPARg) transcriptional activity in hepatic stellate cells. A MAPk/pkcdelta-dependent mechanism. 164
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 159
In vivo effects of rosiglitazone in a human neuroblastoma xenograft 158
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 157
The potential of antidiabetic thiazolidinediones for anticancer therapy. 155
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 154
Apolipoprotein AI regulatory protein 1 (ARP-1) coordinates profibrogenic responses during liver fibrosis 154
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury 152
PPARgamma activation by antidiabetic thiazolidinediones reduces liver fibrosis and hepatic stellate cells activation in vivo 152
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 148
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 148
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 146
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 145
Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transfroming grwoth factor-B1 144
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1 143
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 142
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 141
Ligation-mediated polymerase chain reaction detection of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-hydroxycytosine at the codon 176 of the p53 gene of hepatitis c-associated hepatocellular carcinoma patients 141
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 140
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 140
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 140
Neuropeptide-leukocyte interactions: examples of pharmacological modulation 139
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 139
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 138
Enanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins 137
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 134
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 134
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 131
Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration 131
Genetics, alcohol, and cirrhosis 131
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 130
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 129
Oxydative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism 127
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production 127
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. 127
THU-449-Nuclear orphan receptor COUP-TF2 increases the resistence to anoikis and induces amoeboid movment and metastatic potential in hepatocellular carcinoma 125
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 123
Peroxisome proliferator-activated receptor Gamma (PPAR Gamma) modulates hepatic stellate cells activation. 122
Evidence for tachykinin NK-2b-like receptors in guinea-pig alveolar macrophages. 118
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN 118
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 118
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 117
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 114
Reactive oxigen species (ROS) modulate mitogenic and motogenic responses in human hepatic stellate cells 114
Loss of Hepatic RuvBL1 Causes Chronic Liver Damage and Regeneration, Promoting Hepatocellular Carcinoma 113
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 111
The orphan receptor COUP-TF II (Arp-1) is required for stellate cells activation and is involved in mitogenic responses in activated cells. 109
Peroxisome prolferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells 105
Paracrine cross-talk between pancreatic cancer cells and periacinar stellate cells enhanced tumor progression 105
Helicobacter pylori infection modulates peroxisome proliferator activated receptor gamma (PPARgamma) expression and transcriptional activity. 105
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 96
Pentoxifylline causes degradation of procollagen I produced by human hepatic stellate cells in response to transforming growth factor-beta 1 92
The Impact of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation on the Early Development of Intestinal Fibrosis in Crohn’s Disease 90
Tgf-beta Effects On the Synthesis of Extracellular-matrix Components By Human Fat-storing Cells Are Modulated By Different Matrices 87
Oxidative stress induce collagen synthesis by c-Abl activation in human hepatic stellate cells 86
Genetic polymorphisms in ethanol metabolizing enzymes do not influence the severity of alcoholic liver disease in Italian patients. 85
Tachykinins stimulate Lyso-PAF: acetyl-CoA Acetyltransferase activity in Neutrophils 74
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma 72
null 39
Targeting RuvBL1 disrupts mitochondrial metabolism and structure in hepatocellular carcinoma 8
Totale 14.098
Categoria #
all - tutte 40.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 43 61
2021/2022554 22 48 23 33 25 24 23 28 23 26 126 153
2022/20231.599 124 317 76 136 98 276 202 81 197 5 39 48
2023/2024691 33 65 93 29 58 115 33 125 9 37 44 50
2024/20254.106 142 428 279 662 1.182 486 65 232 161 120 183 166
2025/20263.941 543 620 354 343 496 141 504 205 328 294 113 0
Totale 14.098